Reuters logo
BRIEF-CHMP additionally recommends Avexis to discuss potential in a future meeting with EMA
February 6, 2017 / 1:41 PM / 7 months ago

BRIEF-CHMP additionally recommends Avexis to discuss potential in a future meeting with EMA

Feb 6 (Reuters) - Avexis Inc

* Says CHMP additionally recommended Avexis discuss potential for conditional marketing authorization in a future meeting with EMA

* Says expects to initiate a separate pivotal clinical trial of AVXS-101 in SMA type 1 in United States in first half of 2017

* Says announces single-arm design for European pivotal study of AVXS-101 in SMA type 1 patients

* Says update is based on receipt of scientific advice response from scientific advice working party within CHMP of EMA Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below